Nicotine Mini

Manufacturer
Advagen Pharma Limited | Rubicon Research Limited
Effective date
2026-01-14
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:32:55

Label at a glance#

ProductNicotine Mini
Active ingredientNICOTINE
Label structure3 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drugs Facts
Active ingredient (in each lozenge) Nicotine polacrilex 4 mg Nicotine polacrilex 2 mg
Purpose Stop smoking aid
Use reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
Warnings If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.
Ask a doctor before use if you have heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate. high blood pressure not controlled with medication. Nicotine can increase your blood pressure. stomach ulcer or diabetes history of seizures
Ask a doctor or pharmacist before use if you are using a non-nicotine stop smoking drug taking prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.
Stop use and ask a doctor if mouth problems occur persistent indigestion or severe sore throat occurs irregular heartbeat or palpitations occur you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat you have symptoms of an allergic reaction (such as difficulty breathing or rash)
Keep out of reach of children and pets. Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions (4 mg lozenge)if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.before using this product, read the enclosed User's Guide for complete directions and other important informationbegin using the lozenge on your quit dayif you smoke your first cigarette more than 30 minutes after waking up, use 2 mg nicotine lozengeif you smoke your first cigarette within 30 minutes of waking up,use 4 mg nicotine lozenge according to the following 12 week schedule:

Weeks 1 to 6Weeks 7 to 9Weeks 10 to 12
1 lozenge every 1 to 2
hours
1 lozenge every 2 to 4
hours
1 lozenge every 4 to 8
hours

nicotine lozenge is a medicine and must be used a certain way to get the best results place the lozenge in your mouth and allow the lozenge to slowly dissolve. Minimize swallowing. Do not chew or swallow lozenge. you may feel a warm or tingling sensation occasionally move the lozenge from one side of your mouth to the other until completely dissolved do not eat or drink 15 minutes before using or while the lozenge is in your mouth to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day. It is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.
Directions (2 mg lozenge)if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.before using this product, read the enclosed User's Guide for complete directions and other important informationbegin using the lozenge on your quit dayif you smoke your first cigarette within 30 minutes of waking up, use 4 mg nicotine lozengeif you smoke your first cigarette more than 30 minutes after waking up,use 2 mg nicotine lozenge according to the following 12 week schedule:

Weeks 1 to 6Weeks 7 to 9Weeks 10 to 12
1 lozenge every 1 to 2
hours
1 lozenge every 2 to 4
hours
1 lozenge every 4 to 8
hours

nicotine lozenge is a medicine and must be used a certain way to get the best results place the lozenge in your mouth and allow the lozenge to slowly dissolve. Minimize swallowing. Do not chew or swallow lozenge. you may feel a warm or tingling sensation occasionally move the lozenge from one side of your mouth to the other until completely dissolved do not eat or drink 15 minutes before using or while the lozenge is in your mouth to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day. It is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.
Other information Each lozenge contains: sodium, 5 mg store at 20 oto 25 oC (68 oto 77 oF) keep bottle tightly closed and protect from light TAMPER EVIDENT FEATURE: Do not use if printed seal under cap is broken or missing. retain outer carton for full product uses, directions and warnings.
Inactive ingredients acesulfame potassium, colloidal silicon dioxide, flavors, hydroxypropyl cellulose, magnesium stearate, mannitol, potassium bicarbonate, povidone, sodium alginate, sodium carbonate, sucralose, and xanthan gum.
Questions or comments? Call 866-488-0312 Monday-Friday 9AM-5PM EST
Manufactured by Rubicon Research Ltd.,
Thane 421506, India.
Manufactured for Advagen Pharma Limited,
East Windsor, NJ 08520, USA
Rev: 01/2026

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Container Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Container Labelnicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Container Label

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Carton Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Carton Labelnicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Carton Label

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-54 - 81s Carton Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-54 - 81s Carton Labelnicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-54 - 81s Carton Label

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-55 - 108s Carton Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-55 - 108s Carton Labelnicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-55 - 108s Carton Label

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-56 - 135s Carton Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-56 - 135s Carton Labelnicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-56 - 135s Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Container Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Container Labelnicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Container Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Carton Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Carton Labelnicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Carton Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-54 - 81s Carton Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 81s Carton Labelnicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 81s Carton Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-55 - 108s Carton Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 108s Carton Labelnicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 108s Carton Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-56 - 135s Carton Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 135s Carton Labelnicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 135s Carton Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
359817nicotine 2 MG Oral LozengePSN2
359818nicotine 4 MG Oral LozengePSN2
359817nicotine 2 MG Oral LozengeSCD2
359818nicotine 4 MG Oral LozengeSCD2
359817nicotine 2 MG (as nicotine polacrilex 11.1 MG) Oral LozengeSY2
359817nicotine 2 MG TrocheSY2
359818nicotine 4 MG (as nicotine polacrilex 22.2 MG) Oral LozengeSY2
359818nicotine 4 MG TrocheSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
NICOTINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dbebfdf8-6e0c-cfa8-fdbc-e5d7f1bf1562Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72888-186-53Nicotine Mini27 in 1 BOTTLELOZENGE272
72888-186-53Nicotine Mini1 in 1 CARTONLOZENGE12
72888-186-54Nicotine Mini27 in 1 BOTTLELOZENGE272
72888-186-54Nicotine Mini3 in 1 CARTONLOZENGE32
72888-186-55Nicotine Mini4 in 1 CARTONLOZENGE42
72888-186-55Nicotine Mini27 in 1 BOTTLELOZENGE272
72888-186-56Nicotine Mini27 in 1 BOTTLELOZENGE272
72888-186-56Nicotine Mini5 in 1 CARTONLOZENGE52
72888-187-53Nicotine Mini1 in 1 CARTONLOZENGE12
72888-187-53Nicotine Mini27 in 1 BOTTLELOZENGE272
72888-187-54Nicotine Mini3 in 1 CARTONLOZENGE32
72888-187-54Nicotine Mini27 in 1 BOTTLELOZENGE272
72888-187-55Nicotine Mini27 in 1 BOTTLELOZENGE272
72888-187-55Nicotine Mini4 in 1 CARTONLOZENGE42
72888-187-56Nicotine Mini27 in 1 BOTTLELOZENGE272
72888-187-56Nicotine Mini5 in 1 CARTONLOZENGE52

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 24 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A208875-001NICOTINE POLACRILEXNICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31
A208875-002NICOTINE POLACRILEXNICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31d4dbc9d85df4…
2026-11-14 07:37:172026-10A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31d4dbc9d85df4…
2026-10-15 13:18:302026-09A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31c2088c7a36db…
2026-10-15 13:18:302026-09A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31c2088c7a36db…
2026-09-14 22:38:342026-08A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-3184e616aacf4f…
2026-09-14 22:38:342026-08A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-3184e616aacf4f…
2026-08-18 06:07:402026-07A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31caaa826d4ba7…
2026-08-18 06:07:402026-07A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-3131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-3131067a03dcf5…
2025-08-23 18:47 UTC2025-08A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-316a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-316a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-3103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-3103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-312680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-312680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-315bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-315bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31d06236e962d9…
2024-10-29 15:01 UTC2024-10A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-3179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-3179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-31301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-31301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-311e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-311e350fbaab3a…
2024-05-31 18:47 UTC2024-05A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-318072bd15b7f6…
2024-05-31 18:47 UTC2024-05A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-318072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-315c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-315c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A208875-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2019-10-315d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A208875-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2019-10-315d02ea3f76ae…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Nicotine MiniNICOTINE POLACRILEXAdvagen Pharma Limited7f124912-7ce8-4b9f-8458-46b68362f47d2026-01-14Exact identifier
ndc (package): 72888-187-56
ndc (package): 72888-186-56
ndc (package): 72888-187-53
ndc (package): 72888-186-55
ndc (package): 72888-187-55
ndc (package): 72888-187-54
ndc (package): 72888-186-54
ndc (package): 72888-186-53
ndc (product): 72888-187
ndc (product): 72888-186
ndc11 (package): 72888018653
ndc11 (package): 72888018756
ndc11 (package): 72888018654
ndc11 (package): 72888018754
ndc11 (package): 72888018655
ndc11 (package): 72888018656
ndc11 (package): 72888018753
ndc11 (package): 72888018755
spl id: 4859954c-e904-be9f-e063-6294a90a1804
spl set id: 7f124912-7ce8-4b9f-8458-46b68362f47d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.